HIF1A and melanoma: In another melanoma study, Lee et al. [41] reported that ablation of BMAL1 expression fostered an immunosuppressive subtype of CAMs that promoted melanoma cell proliferation by impairing mitochondrial metabolism and activating HIF-1A.